Featured

Global Regulatory and U.S. Reimbursement Seminar



Published
The Medical Alley Association and its partners, Investissement Quebec and the Quebec Government Office in Chicago, present a seminar preparing new market entrants for global regulation and U.S. reimbursement. Medical Devices and Digital Health products face a range of regulations in the United States, primarily from the Food & Drug Administration (FDA). Further, reimbursement, or payment for various health services, in the U.S. differs significantly compared to most other countries.

A mix of public and private, national and regional, and separate of medical, dental, vision, and pharmacy benefits means your path to securing payment can be complex and fraught with risk. In this session you will learn the latest on FDA regulations and strategies to employ in launching your first product in the U.S. as well as the fundamentals of U.S. reimbursement and how to pursue it for your company.

We were joined for this webinar by Kirk Honour and Joseph Sierra of NAMSA, who offered their insights on the regulatory hurdles and reimbursement issues companies should consider when entering the U.S. market.
Category
Management
Be the first to comment